Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways. - Moysidou GS; Garantziotis P; Sentis G; Nikoleri D; Malissovas N; Nikoloudaki M; Stergioti EM; Polia S; Paschalidis N; Filia A; Grigoriou M; Nikolopoulos D; et al. (Annals of the rheumatic diseases, 2025)